Select Medical Holdings Corporation (SEM) Revenue History
Annual and quarterly revenue from 2005 to present
SEM Revenue Over Time (2005–2025)
SEM Revenue Growth History
18 of 20 years with positive growth- FY2005 revenue growth
- N/A
- FY2006 revenue growth
- -0.4%
- FY2007 revenue growth
- +7.6%
- FY2008 revenue growth
- +8.1%
- FY2009 revenue growth
- +4.0%
- FY2010 revenue growth
- +6.7%
- FY2011 revenue growth
- +17.3%
- FY2012 revenue growth
- +5.2%
- FY2013 revenue growth
- +0.9%
- FY2014 revenue growth
- +3.0%
- FY2015 revenue growth
- +22.1%
- FY2016 revenue growth
- +14.5%
- FY2017 revenue growth
- +3.7%
- FY2018 revenue growth
- +14.3%
- FY2019 revenue growth
- +7.3%
- FY2020 revenue growth
- +1.4%
- FY2021 revenue growth
- +12.2%
- FY2022 revenue growth
- +2.1%
- FY2023 revenue growth
- +5.2%
- FY2024 revenue growth
- -22.2%
- FY2025 revenue growth
- +5.1%
| Quarter | Revenue | YoY |
|---|---|---|
| Q1 2026 | $1.42B | +5.0% |
| Q4 2025 | $1.40B | +1239.3% |
| Q3 2025 | $1.36B | -22.6% |
| Q2 2025 | $1.34B | +4.5% |
| Q1 2025 | $1.35B | -24.4% |
| Q4 2024 | $-122,587,000 | -110.1% |
| Q3 2024 | $1.76B | +5.7% |
| Q2 2024 | $1.28B | -23.5% |
Multi-year avg. share of annual revenue by fiscal quarter
Revenue Breakdown (FY 2025)
SEM's revenue distribution by segment and geography for fiscal year 2025
By Product/Segment
SEM Revenue Analysis (2005–2025)
Current Revenue & Growth
As of June 21, 2026, Select Medical Holdings Corporation (SEM) generated trailing twelve-month (TTM) revenue of $5.52 billion, reflecting solid growth of +5.0% year-over-year. The most recent quarter (Q1 2026) recorded $1.42 billion in revenue, up 1.8% sequentially.
Historical Growth Trajectory
SEM's 5-year compound annual growth rate (CAGR) stands at -0.3%, indicating revenue contraction over this period. The 3-year CAGR of -4.9% is below the 5-year average, signalling a growth deceleration in recent years. Select Medical Holdings Corporation's highest annual revenue of $6.66 billion was recorded in 2023.
Revenue by Segment
SEM's revenue is primarily driven by Health Care, Patient Service, Non-Medicare (61%), Health Care, Patient Service, Medicare (29%), and Service, Other (10%). With over half of revenue concentrated in Health Care, Patient Service, Non-Medicare, the company has a focused business model while developing other growth vectors.
Peer Comparison
Compared to Healthcare sector peers — including ENSG (+19.2% YoY), ACHC (+6.8% YoY), and UHS (+10.4% YoY) — SEM has underperformed the peer group in revenue growth. Compare SEM vs ENSG →
SEM Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| SEMCurrent | $5.5B | +5.0% | -0.3% | 6.1% | |
 ENSG | $5.1B | +19.2% | +16.1% | 8.6% | |
 ACHC | $3.3B | +6.8% | +9.7% | 11.7% | |
 UHS | $17.4B | +10.4% | +8.5% | 11.5% | |
 SGRY | $3.3B | +5.4% | +12.2% | 11.8% | |
 HCA | $75.6B | +7.1% | +8.0% | 15.8% |
SEM Historical Revenue Data (2005–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $5.45B | +5.1% | $629.3M | 11.5% | $334.6M | 6.1% |
| 2024 | $5.19B | -22.2% | $633.6M | 12.2% | $268.3M | 5.2% |
| 2023 | $6.66B | +5.2% | $932.0M | 14.0% | $554.9M | 8.3% |
| 2022 | $6.33B | +2.1% | $733.4M | 11.6% | $403.3M | 6.4% |
| 2021 | $6.20B | +12.2% | $919.4M | 14.8% | $713.8M | 11.5% |
| 2020 | $5.53B | +1.4% | $821.3M | 14.8% | $567.7M | 10.3% |
| 2019 | $5.45B | +7.3% | $812.9M | 14.9% | $471.9M | 8.7% |
| 2018 | $5.08B | +14.3% | $740.2M | 14.6% | $417.3M | 8.2% |
| 2017 | $4.44B | +3.7% | $709.4M | 16.0% | $355.9M | 8.0% |
| 2016 | $4.29B | +14.5% | $621.2M | 14.5% | $299.8M | 7.0% |
| 2015 | $3.74B | +22.1% | $531.2M | 14.2% | $274.8M | 7.3% |
| 2014 | $3.07B | +3.0% | $482.7M | 15.7% | $284.5M | 9.3% |
| 2013 | $2.98B | +0.9% | $480.2M | 16.1% | $301.4M | 10.1% |
| 2012 | $2.95B | +5.2% | $505.4M | 17.1% | $336.9M | 11.4% |
| 2011 | $2.80B | +17.3% | $495.9M | 17.7% | $310.7M | 11.1% |
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
21+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
SEM — Frequently Asked Questions
Quick answers to the most common questions about buying SEM stock.
Is SEM's revenue growth accelerating or slowing?
SEM revenue growth is slowing. TTM revenue is $5.5B, up +5.0% year-over-year — below the 5-year CAGR of -0.3%. The deceleration suggests maturing end-markets or increased competition.
What is SEM's revenue history from 2005 to 2026?
Select Medical Holdings Corporation (SEM) revenue history spans 2005 to 2026. TTM revenue as of 2026 is $5.5B, growing at +5.0% YoY. The 5-year CAGR is -0.3%. Complete annual and quarterly revenue figures are available on this page, including gross profit, operating income, and margin trends.
What is SEM's long-term revenue growth rate (CAGR)?
Select Medical Holdings Corporation's 5-year revenue CAGR of -0.3% reflects the variable nature of its business expansion. As of 2026, the current YoY growth rate of +5.0% is below this long-term average. CAGR is the most reliable measure of sustained revenue momentum for SEM.
Why does SEM's quarterly revenue fluctuate?
SEM quarterly revenue can fluctuate significantly between periods. A quarter-over-quarter (QoQ) change does not always indicate a trend; comparing the same quarter year-over-year (YoY) is a more reliable signal for underlying growth. Select Medical Holdings Corporation's revenue data from 2005 to 2026 shows full historical quarterly detail on this page.
How is SEM's revenue distributed by segment?
SEM reports revenue broken down by product line and geographic region. The segment breakdown on this page shows which business units contribute the most to total revenue as of the latest fiscal year. Concentration in a single segment above 50% indicates category dependence, while a diversified mix signals more resilient revenue streams.
How does SEM's revenue compare to industry peers?
Select Medical Holdings Corporation (SEM) with TTM revenue of $5.5B and +5.0% YoY growth can be benchmarked against sector peers using the comparison table on this page. Revenue growth relative to peers indicates market share gains or losses. The peer section shows TTM revenue, YoY growth, and operating margin for direct comparisons.